BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34472711)

  • 1. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
    Hu X; Zhu H; Zhang X; He X; Xu X
    Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis.
    Ding Z; Ding Q; Li H
    Transl Cancer Res; 2024 Mar; 13(3):1458-1478. PubMed ID: 38617524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
    Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
    Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment.
    Wu Z; Pan T; Li W; Zhang YH; Guo SH; Liu Y; Zhang L; Wang ZY
    Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38642258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration.
    Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L
    Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling HOXB7 as a novel diagnostic and prognostic biomarker through pan-cancer computer screening.
    Li C; Mao X; Song L; Sheng J; Yang L; Huang X; Wang L
    Comput Biol Med; 2024 Jun; 176():108562. PubMed ID: 38728993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer.
    Wang Y; Chen R; Zhang J; Zeng P
    PLoS One; 2024; 19(4):e0299949. PubMed ID: 38635758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value and immunological role of MVP in pan-cancer study.
    Li C; Gao M; Zha N; Guo G
    Aging (Albany NY); 2024 May; 16(10):8497-8510. PubMed ID: 38713157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis.
    Wang ZQ; Wu ZX; Wang ZP; Bao JX; Wu HD; Xu DY; Li HF; Xu YY; Wu RX; Dai XX
    BMC Cancer; 2024 Mar; 24(1):353. PubMed ID: 38504158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1b-mediated AML progression.
    Lin HY; M Hosseini M; McClatchy J; Villamor-Payà M; Jeng S; Bottomly D; Tsai CF; Posso C; Jacobson J; Adey AC; Gosline SJC; Liu T; McWeeney SK; Stracker TH; Agarwal A
    Blood; 2024 Mar; ():. PubMed ID: 38498025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis reveals potential immunological and prognostic roles of COA6 in human cancers and preliminary exploration of COA6 in bladder cancer.
    Luo H; Wang Z
    Cell Signal; 2024 May; 117():111111. PubMed ID: 38395184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study.
    Zheng P; Tan Y; Liu Q; Wu C; Kang J; Liang S; Zhu L; Yan K; Zeng L; Chen B
    Heliyon; 2024 Mar; 10(5):e26993. PubMed ID: 38468942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFDP1 is a potential diagnostic, immunological and prognostic biomarker in pan-cancer.
    Zhang Y; Wang J; Zhang G; Cai H
    Asian J Surg; 2024 May; 47(5):2481-2483. PubMed ID: 38302349
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to: "Identification of SLC12A8 as a valuable prognostic biomarker and immunotherapeutic target by comprehensive pan-cancer analysis" [Gene 903 (2024) 148211].
    Yu D; Ma H; Li D; Tang H; Li W; Li M
    Gene; 2024 May; 908():148267. PubMed ID: 38382297
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
    Ma J; Han W; Lu K
    Front Oncol; 2021; 11():711756. PubMed ID: 34490109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.
    Zhang W; Gao Z; Guan M; Liu N; Meng F; Wang G
    Front Oncol; 2021; 11():731547. PubMed ID: 34568067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Analysis Identified
    Chen J; Mai H; Chen H; Zhou B; Hou J; Jiang DK
    Front Mol Biosci; 2021; 8():693651. PubMed ID: 34490347
    [No Abstract]   [Full Text] [Related]  

  • 20. A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers.
    Gu Y; Tang S; Wang Z; Cai L; Lian H; Shen Y; Zhou Y
    Bioengineered; 2021 Dec; 12(1):6166-6185. PubMed ID: 34486492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.